CMS certification 030087
Honorhealth Scottsdale Shea Medical Center
9003 East Shea Boulevard, Scottsdale, AZ 85260
Honorhealth Scottsdale Shea Medical Center has a CMS overall rating of 3 out of 5 stars. 72% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on 2. Emergency patients spend a median of 3 h in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 560 completed surveys, 23% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | AZ | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 374 visits sampled · US median for EDs of the same volume: 3 h 21 min | 3 h | 2 h 56 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 11 visits sampled | 5 h 43 min | 4 h 33 min | 4 h 17 min |
| Left before being seen Lower is better · 83,071 patients | 2% | 2% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 27 patients | 56% | 70% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 167 patients | 58% | 59% | 65% |
How Honorhealth Scottsdale Shea Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Honorhealth Scottsdale Shea Medical CenterThis hospital | 3/5 | 72% | 3 h | 4 better 2 worse |
| Honorhealth Scottsdale Thompson Peak Med CtrSame city | 5/5 | 84% | 2 h 49 min | 2 better |
| Honorhealth Scottsdale Osborn Medical CenterSame city | 3/5 | 77% | 3 h 11 min | 3 better 3 worse |
| Banner Gateway Medical CenterSame county · Gilbert | 3/5 | 73% | 3 h 44 min | 1 better |
| Banner Ocotillo Medical CenterSame county · Chandler | 3/5 | 74% | 3 h | 1 better 2 worse |
| Chandler Regional Medical CenterSame county · Chandler | 4/5 | 72% | 2 h 22 min | 6 better 1 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Scottsdale.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 5,335 cases | Too few cases | 3.4% | 3.9% |
| Heart attack 261 cases | Too few cases | 10.7% | 11.9% |
| Heart failure 673 cases | Too few cases | 9.2% | 11.1% |
| Pneumonia 730 cases | Too few cases | 13.4% | 15.2% |
| Stroke 230 cases | Too few cases | 10.7% | 11.9% |
| COPD 125 cases | Too few cases | 8.4% | 8.6% |
| Heart bypass surgery (CABG) 152 cases | Too few cases | 1.9% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 1.06 likely 0.82 – 1.31 | 1 |
| After hip or knee replacement 165 cases | Too few cases | 4.4% | 4.1% |
| Deaths after a serious but treatable surgical complication 165 cases | No different | 190.63 per 1,000 likely 146.52 per 1,000 – 234.74 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 8,653 cases | No different | 0.52 per 1,000 likely 0 per 1,000 – 1.09 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 11,047 cases | No different | 0.27 per 1,000 likely 0.09 per 1,000 – 0.44 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 11,852 cases | No different | 0.22 per 1,000 likely 0.04 per 1,000 – 0.4 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 3,330 cases | No different | 2.83 per 1,000 likely 1.6 per 1,000 – 4.05 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,933 cases | No different | 2.12 per 1,000 likely 0.87 per 1,000 – 3.37 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,943 cases | No different | 7.71 per 1,000 likely 3.65 per 1,000 – 11.76 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 3,567 cases | No different | 4.28 per 1,000 likely 2.66 per 1,000 – 5.91 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,951 cases | No different | 7.09 per 1,000 likely 4.4 per 1,000 – 9.77 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 975 cases | No different | 2.08 per 1,000 likely 0.67 per 1,000 – 3.49 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 2,814 cases | No different | 1.53 per 1,000 likely 0.73 per 1,000 – 2.34 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.36 likely 0.15 – 0.75 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.44 likely 0.18 – 0.92 | 1 |
| Surgical site infections after colon surgery | Worse | 2.11 likely 1.2 – 3.46 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 0.9 likely 0.36 – 1.87 | 1 |
| MRSA bloodstream infections | No different | 0.6 likely 0.19 – 1.44 | 1 |
| C. diff intestinal infections | Better | 0.3 likely 0.17 – 0.48 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 354 cases | Too few cases | 14.7% | 14.4% |
| Readmitted after heart failure 864 cases | Too few cases | 19.9% | 21.3% |
| Readmitted after pneumonia 844 cases | Too few cases | 16.9% | 17.3% |
| Readmitted after COPD 164 cases | Too few cases | 22.1% | 20% |
| Readmitted after heart bypass surgery 154 cases | Too few cases | 11.4% | 11% |
| Readmitted after hip or knee replacement 166 cases | Too few cases | 6.5% | 5.8% |
| Days back in hospital after a heart attack 308 cases | Too few cases | 4.6 days per 100 | — |
| Days back in hospital after heart failure 767 cases | Too few cases | -2 days per 100 | — |
| Days back in hospital after pneumonia 752 cases | Too few cases | 4.6 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 1,287 cases | No different | 12.7 per 1,000 likely 9.9 per 1,000 – 16.2 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 26 cases | No different | 11.1 per 100 likely 7.5 per 100 – 16.5 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 26 cases | No different | 5 per 100 likely 3.1 per 100 – 8.1 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 1,744 cases | No different | 0.9 likely 0.8 – 1.1 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
94 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Pharmacist | 16 |
| Physician Assistant | 13 |
| Anatomic Pathology & Clinical Pathology | 10 |
| Anesthesiology | 9 |
| Family | 7 |
| Registered Nurse | 4 |
| Acute Care | 3 |
| Nurse Anesthetist, Certified Registered | 3 |
| Anatomic Pathology | 2 |
| Critical Care Medicine | 2 |
| Electroneurodiagnostic | 2 |
| Neurology | 2 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $2.6M
- 2020 $2.1M
- 2021 $3.8M
- 2022 $3.8M
- 2023 $3.1M
- 2024 $1.7M
- 2025 $1.6M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Grants | $160,000 | 4 |
| Debt forgiveness | $3,546 | 2 |
| Space rental and facility fees | $3,010 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Merck Sharp & Dohme LLC | $1.1M | 9 |
| Janssen Research & Development, LLC | $156,625 | 48 |
| Siemens Medical Solutions USA, Inc. | $143,014 | 4 |
| Syndax Pharmaceuticals, Inc. | $98,448 | 13 |
| CardioFocus, Inc. | $40,059 | 4 |
| Procyrion, Inc. | $32,144 | 1 |
| Biosense Webster, Inc. | $20,000 | 1 |
| Ethicon US, LLC | $3,010 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of… Merck Sharp & Dohme LLC | $504,849 |
| A Phase 3 Randomized, Open-label, Active-comparator Controlled Clinical Study of Pembrolizumab vs. Platinum Doublet Chemotherapy in Participants With… Merck Sharp & Dohme LLC | $181,819 |
| A Multicenter Phase I,Ib Dose Escalation Study of WTX 124 as Monotherapy and in Combination with Pembrolizumab in Patients with Selected Advanced or … Merck Sharp & Dohme LLC | $170,400 |
| A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral … Janssen Research & Development, LLC | $141,290 |
| A Phase 1b,2 Open-Label, Dose Escalation of ADG106 in Combination with Pembrolizumab Anti PD-1 Antibody and Expansion of ADG106 with or without Pembr… Merck Sharp & Dohme LLC | $121,578 |
| A PHASE 1/2 STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND EFFICACY OF SNDX-5613 IN PATIENTS WITH COLORECTAL … Syndax Pharmaceuticals, Inc. | $98,448 |
| A Phase 3, Randomized, Double-Blind Study of Pembrolizumab versus Placebo in Combination With Paclitaxel With or Without Bevacizumab for the Treatmen… Merck Sharp & Dohme LLC | $66,245 |
| POST APPROVAL STUDY OF HEARTLIGHT ENDOSCOPIC ABLATION SYSTEM FOR THE TREATMENT OF ATRIAL FIBRILLATION CardioFocus, Inc. | $40,059 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Honorhealth Scottsdale Shea Medical Center
Is Honorhealth Scottsdale Shea Medical Center a good hospital?
Honorhealth Scottsdale Shea Medical Center has a CMS overall rating of 3 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on 2. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Honorhealth Scottsdale Shea Medical Center?
72% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 560 completed HCAHPS surveys.
How long is the wait in the Honorhealth Scottsdale Shea Medical Center emergency room?
Emergency patients spend a median of 3 h in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 2% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Honorhealth Scottsdale Shea Medical Center receive money from drug and device companies?
Drug and device makers reported $1.6M in payments to Honorhealth Scottsdale Shea Medical Center for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.